Research by CTSI-Supported Investigator Has Led to First-in-Human Clinical Trial

Early research by Indiana University School of Medicine’s Milan Radovich, PhD, whose work was supported by the Indiana CTSI, has led to the launch of a first-in-human clinical trial that aims to treat an aggressive type of breast cancer.
Dr. Radovich, who is now an assistant professor in the IU School of Medicine’s Department of Surgery, received a Pre-doctoral (TL1) Award from the Indiana CTSI in 2010-2011 for his research project titled “Novel targets in triple negative breast cancer.”
He says that research has informed the clinical trial going on now, which is using precision medicine to target multiple genetic culprits suspected of helping the cancer grow — inspired by a popular arcade game.
Read more.